Published in Clin Exp Immunol on November 01, 1999
Neutrophil-mediated mycobacteriocidal immunity in the lung during Mycobacterium bovis BCG infection in C57BL/6 mice. Infect Immun (2002) 1.52
Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection. Am J Respir Crit Care Med (2010) 1.03
Autoantibody prevalence in active tuberculosis: reactive or pathognomonic? BMJ Open (2013) 0.75
Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl (1968) 60.35
The cell biology of macrophage activation. Annu Rev Immunol (1984) 7.27
Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages. Biochem Biophys Res Commun (1976) 4.59
Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol (1993) 4.23
Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J Immunol (1994) 2.52
Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J Immunol (1994) 2.48
Capacity of human neutrophils to kill Mycobacterium tuberculosis. J Infect Dis (1987) 2.43
Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J Immunol (1996) 2.41
CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J Exp Med (1989) 2.35
Neutrophil-macrophage cooperation in the host defence against mycobacterial infections. Microb Pathog (1989) 2.01
Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. J Immunol (1995) 1.76
Free radicals and phagocytic cells. FASEB J (1995) 1.65
Nonopsonic binding of Mycobacterium tuberculosis to complement receptor type 3 is mediated by capsular polysaccharides and is strain dependent. Infect Immun (1997) 1.48
Chemokine secretion by human polymorphonuclear granulocytes after stimulation with Mycobacterium tuberculosis and lipoarabinomannan. Infect Immun (1997) 1.47
Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radic Biol Med (1996) 1.47
Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. J Immunol (1996) 1.46
Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils. Blood (1998) 1.36
Effect of Mycobacterium tuberculosis-derived sulfolipid I on human phagocytic cells. Infect Immun (1988) 1.25
Interferon-gamma-activated human granulocytes kill ingested Mycobacterium fortuitum more efficiently than normal granulocytes. Eur J Immunol (1990) 1.24
Structure and serological specificity of the K13-antigenic polysaccharide (K13 antigen) of urinary tract-infective Escherichia coli. Infect Immun (1979) 1.22
Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells. Infect Immun (1996) 1.21
Cell surface expression of fMet-Leu-Phe receptors on human neutrophils. Correlation to changes in the cytosolic free Ca2+ level and action of phorbol myristate acetate. J Clin Invest (1987) 1.13
Activation of human neutrophils by Mycobacterium tuberculosis-derived sulfolipid-1. J Immunol (1991) 1.13
Rapid redistribution of clathrin onto macrophage plasma membranes in response to Fc receptor-ligand interaction during frustrated phagocytosis. J Cell Biol (1986) 1.13
Lectin-like inhibition of immune complex receptor-mediated stimulation of neutrophils. Effects on cytosolic calcium release and superoxide production. J Immunol (1993) 1.06
Structure of the major triglycosyl phenol-phthiocerol of Mycobacterium tuberculosis (strain Canetti). Eur J Biochem (1987) 1.05
Neutrophil bactericidal activity against Staphylococcus aureus adherent on biological surfaces. Surface-bound extracellular matrix proteins activate intracellular killing by oxygen-dependent and -independent mechanisms. J Clin Invest (1990) 1.00
The respiratory burst oxidase and the molecular basis of chronic granulomatous disease. Am J Hematol (1991) 0.98
Structure of the 2-keto-3-deoxy-D-manno-octonic-acid-containing capsular polysaccharide (K12 antigen) of the urinary-tract-infective Escherichia coli O4:K12:H-. Eur J Biochem (1983) 0.97
A novel mannose containing phenolic glycolipid from Mycobacterium kansasii. J Biol Chem (1987) 0.94
Monoglycosyldiacylphenol-phthiocerol of Mycobacterium tuberculosis and Mycobacterium bovis. Biochim Biophys Acta (1988) 0.93
A comparative serological study of antigenic glycolipids from Mycobacterium tuberculosis. Tuber Lung Dis (1992) 0.90
Neutrophil control of formylmethionyl-leucyl-phenylalanine induced mobilization of secretory vesicles and NADPH-oxidase activation: effect of an association of the ligand-receptor complex to the cytoskeleton. Biochim Biophys Acta (1994) 0.85
Absolute configuration of the unique 2,6-dideoxy-4-O-methyl-arabino-hexopyranose of the major phenolic glycolipid antigen from Mycobacterium kansasii. Eur J Biochem (1987) 0.85
Localization of the luminol-dependent chemiluminescence reaction in human granulocytes. J Biolumin Chemilumin (1989) 0.83
Activation of the oxygen-radical-generating system in granules of intact human neutrophils by a calcium ionophore (ionomycin). Biochim Biophys Acta (1992) 0.82
Surface-related triggering of the neutrophil respiratory burst. Characterization of the response induced by IgG adsorbed to hydrophilic and hydrophobic glass surfaces. Clin Exp Immunol (1997) 0.80
Parameters of neutrophil activation: models of priming and deactivation. Prog Clin Biol Res (1989) 0.80
Neutrophil Priming Mechanisms of Sulfolipid-I and N-Formyl-Methionyl-Leucyl-Phenylalanine. J Biomed Sci (1994) 0.79
Characterisation of phenolic glycolipids from Mycobacterium marinum. Biochim Biophys Acta (1990) 0.78
Down-regulatory effect of Mycobacterium leprae cell wall lipids on phagocytosis, oxidative respiratory burst and tumour cell killing by mouse bone marrow derived macrophages. Scand J Immunol (1997) 0.77
Analysis of dimycocerosates of glycosylphenolphthiocerols in the identification of some clinically significant mycobacteria. Eur J Clin Microbiol (1987) 0.76
Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet (1986) 7.09
Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol (1997) 5.18
Stressful life events and Graves' disease. Lancet (1991) 3.63
Respiratory burst in human neutrophils. J Immunol Methods (1999) 3.16
Mycolic acid patterns of some species of Mycobacterium. Arch Microbiol (1984) 3.02
Lipid composition in the classification and identification of acid-fast bacteria. Soc Appl Bacteriol Symp Ser (1980) 2.82
Differentiation of Mycobacterium, Nocardia, and related taxa by thin-layer chromatographic analysis of whole-organism methanolysates. J Gen Microbiol (1975) 2.70
Evaluation of the E test for susceptibility testing of anaerobic bacteria. J Clin Microbiol (1991) 2.59
Identification and characterization of SarH1, a new global regulator of virulence gene expression in Staphylococcus aureus. Mol Microbiol (2000) 2.57
The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group. N Engl J Med (1990) 2.46
Multiple choice questions in Sudan medical schools: teachers views. Saudi Med J (2000) 2.44
Distribution of menaquinones in actinomycetes and corynebacteria. J Gen Microbiol (1977) 2.28
Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res (1999) 2.25
In-vitro measurement of static pressure distribution in synovial joints--Part I: Tibial surface of the knee. J Biomech Eng (1983) 2.16
Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J Virol (1994) 2.07
Semantide- and chemotaxonomy-based analyses of some problematic phenotypic clusters of slowly growing mycobacteria, a cooperative study of the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1996) 2.02
Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media. J Clin Microbiol (1998) 1.99
Investigation of the laminate structure of lumbar disc anulus fibrosus. Spine (Phila Pa 1976) (1990) 1.95
Chemical transformations in individual ultrasmall biomimetic containers. Science (1999) 1.93
HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase. Virology (1993) 1.92
Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis. J Biol Chem (2000) 1.92
Intra- and extracellular events in luminol-dependent chemiluminescence of polymorphonuclear leukocytes. Infect Immun (1984) 1.77
Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. J Immunol (1995) 1.76
Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes. Infect Immun (1983) 1.76
Mycolic acid patterns of representative strains of Mycobacterium fortuitum, 'Myobacterium peregrinum' and Mycobacterium smegmatis. J Gen Microbiol (1984) 1.67
Mechanical response of a lumbar motion segment in axial torque alone and combined with compression. Spine (Phila Pa 1976) (1986) 1.65
A survey of the structures of mycolic acids in Corynebacterium and related taxa. J Gen Microbiol (1982) 1.64
Substrate binding site of naphthalene 1,2-dioxygenase: functional implications of indole binding. J Mol Biol (2000) 1.62
Free mycolic acids as criteria in the classification of Nocardia and the 'rhodochrous' complex. J Gen Microbiol (1976) 1.59
Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates. Proc Natl Acad Sci U S A (1996) 1.54
Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre. Clin Exp Immunol (1984) 1.50
1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D- ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"-oxathiole 2",2"-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activity. J Med Chem (1994) 1.50
Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils. Mol Pharmacol (1986) 1.49
Studies on the mycolic acids from the walls of Mycobacterium microti. J Gen Microbiol (1982) 1.49
Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radic Biol Med (1996) 1.47
A new group (type 3) of Mycobacterium celatum isolated from AIDS patients in the London area. Int J Syst Bacteriol (1995) 1.45
The human nm23-H4 gene product is a mitochondrial nucleoside diphosphate kinase. J Biol Chem (2000) 1.44
T-matrix computations of light scattering by red blood cells. Appl Opt (1998) 1.43
Towards sustainable delivery of health services in Afghanistan: options for the future. Bull World Health Organ (2007) 1.41
The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor. Blood (2000) 1.41
Autoimmune thyroid dysfunction in the postpartum period. J Clin Endocrinol Metab (1984) 1.41
Making a start with district health libraries. World Health Forum (1994) 1.40
Fatty acid composition of some mycolic acid-containing coryneform bacteria. J Gen Microbiol (1982) 1.40
[Smoking and goiter. Sex, heredity and stress are stronger risk factors]. Lakartidningen (1993) 1.39
The mycolic acids of Mycobacterium chelonei. J Gen Microbiol (1982) 1.39
The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis. J Clin Invest (1978) 1.37
Stress analysis of the lumbar disc-body unit in compression. A three-dimensional nonlinear finite element study. Spine (Phila Pa 1976) (1984) 1.37
Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils. Blood (1998) 1.36
Aerobic mineralization of trichloroethylene, vinyl chloride, and aromatic compounds by rhodococcus species. Appl Environ Microbiol (1994) 1.35
Protean manifestation of gastrointestinal tuberculosis: report on 130 patients. J Clin Gastroenterol (1995) 1.35
Mycobacterium cookii sp. nov. Int J Syst Bacteriol (1990) 1.34
The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J Biol Chem (2001) 1.34
Phenotypic detection of methicillin resistance in Staphylococcus aureus by disk diffusion testing and Etest on Mueller-Hinton agar. J Clin Microbiol (2006) 1.33
Tensile stress-strain characteristics of the human meniscal material. J Biomech (1995) 1.33
Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases. Pharmacol Ther (2000) 1.32
Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression. Proc Natl Acad Sci U S A (1998) 1.32
Oral candida albicans in HIV infection. Scand J Infect Dis (1987) 1.31
Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis. Antimicrob Agents Chemother (1999) 1.30
Replacement of acidic phosphates by acidic glycolipids in Pseudomonas diminuta. Nature (1974) 1.29
Evidence for integrated EBV genomes in Raji cellular DNA. Nucleic Acids Res (1984) 1.27
Phosphorylation of deoxycytidine analog monophosphates by UMP-CMP kinase: molecular characterization of the human enzyme. Mol Pharmacol (1999) 1.27
Knocking-out concentrations of HIV-1-specific inhibitors completely suppress HIV-1 infection and prevent the emergence of drug-resistant virus. Virology (1993) 1.27
Pharmacokinetics and absorption of foscarnet after intravenous and oral administration to patients with human immunodeficiency virus. Clin Pharmacol Ther (1988) 1.27
Numerical classification of Mycobacterium farcinogenes, Mycobacterium senegalense and related taxa. J Gen Microbiol (1983) 1.27
Biochemical characterization of acyl carrier protein (AcpM) and malonyl-CoA:AcpM transacylase (mtFabD), two major components of Mycobacterium tuberculosis fatty acid synthase II. J Biol Chem (2001) 1.26
Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors. Proc Natl Acad Sci U S A (1993) 1.24
Khat consumption: a pharmacological review. Drug Alcohol Depend (1989) 1.23
Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine. Blood (2000) 1.22
Separation and characterization of individual mycolic acids in representative mycobacteria. Microbiology (2001) 1.22
Analysis of cellular fatty acids by gas chromatography as a tool in the identification of medically important coryneform bacteria. J Appl Bacteriol (1985) 1.21
Numerical analysis of fatty acid profiles in the identification of staphylococci. J Gen Microbiol (1985) 1.20
Phosphorylation of uridine and cytidine nucleoside analogs by two human uridine-cytidine kinases. Mol Pharmacol (2001) 1.19
Pattern of formylmethionyl-leucyl-phenylalanine-induced luminol- and lucigenin-dependent chemiluminescence in human neutrophils. Infect Immun (1985) 1.19
Methods used in the molecular epidemiology of tuberculosis. Clin Microbiol Infect (2002) 1.18
In-vitro measurement of static pressure distribution in synovial joints--Part II: Retropatellar surface. J Biomech Eng (1983) 1.18
Naphthalene-induced respiratory tract toxicity: metabolic mechanisms of toxicity. Drug Metab Rev (2002) 1.18
Identification of CD66a and CD66b as the major galectin-3 receptor candidates in human neutrophils. J Immunol (1999) 1.18
99mTechnetium dimercaptosuccinic acid scintigraphy in the diagnosis of acute pyelonephritis in rats. Pediatr Nephrol (1990) 1.17
The return of life-threatening puerperal sepsis caused by group A streptococci. Am J Obstet Gynecol (1993) 1.16
Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient. J Clin Invest (1984) 1.15
Thin-layer chromatographic analysis of mycolic acid and other long-chain components in whole-organism methanolysates of coryneform and related taxa. J Gen Microbiol (1976) 1.15
Effect of the convulsive agent 3-mercaptopropionic acid on the levels of GABA, other amino acids and glutamate decarboxylase in different regions of the rat brain. Biochem Pharmacol (1974) 1.15
Mycolic acid patterns of four vaccine strains of Mycobacterium bovis BCG. J Gen Microbiol (1983) 1.14
Mycolic acid patterns of representatives of Mycobacterium bovis BCG. J Gen Microbiol (1984) 1.14
Cell surface expression of fMet-Leu-Phe receptors on human neutrophils. Correlation to changes in the cytosolic free Ca2+ level and action of phorbol myristate acetate. J Clin Invest (1987) 1.13
Cloning and characterization of the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster. J Biol Chem (1999) 1.13
Substrate specificity of mitochondrial 2'-deoxyguanosine kinase. Efficient phosphorylation of 2-chlorodeoxyadenosine. J Biol Chem (1993) 1.12
Structural elucidation of a novel family of acyltrehaloses from Mycobacterium tuberculosis. Biochemistry (1992) 1.11
Synthesis of methyl (Z)-tetracos-5-enoate and both enantiomers of ethyl (E)-6-methyltetracos-4-enoate: possible intermediates in the biosynthesis of mycolic acids in mycobacteria. Chem Phys Lipids (1993) 1.11
Cloning of the cDNA and chromosome localization of the gene for human thymidine kinase 2. J Biol Chem (1997) 1.11
Neutrophil killing of two type 1 fimbria-bearing Escherichia coli strains: dependence on respiratory burst activation. Infect Immun (1990) 1.10
Lipid domains of mycobacteria studied with fluorescent molecular probes. Mol Microbiol (1999) 1.10
Impact of immigration on tuberculosis epidemiology in a low-incidence country. Clin Microbiol Infect (2010) 1.10